-
1
-
-
58149112824
-
The atherosclerotic plaque
-
Mundo-Sagardía JA, Figueroa Y, Altieri PI, Banchs HL, Escobales N, Crespo MJ. The atherosclerotic plaque. P R Health Sci J 2008;27:241-246.
-
(2008)
P R Health Sci J
, vol.27
, pp. 241-246
-
-
Mundo-Sagardía, J.A.1
Figueroa, Y.2
Altieri, P.I.3
Banchs, H.L.4
Escobales, N.5
Crespo, M.J.6
-
2
-
-
0022479411
-
Atherogenicity of blood serum from patients with coronary heart disease
-
Chazov EI, Tertov VV, Orekhov AN, Lyakishev AA, Perova NV, Kurdanov KA, Khashimov KA, Novikov ID, Smirnov VN. Atherogenicity of blood serum from patients with coronary heart disease. Lancet 1986;2:595-598.
-
(1986)
Lancet
, vol.2
, pp. 595-598
-
-
Chazov, E.I.1
Tertov, V.V.2
Orekhov, A.N.3
Lyakishev, A.A.4
Perova, N.V.5
Kurdanov, K.A.6
Khashimov, K.A.7
Novikov, I.D.8
Smirnov, V.N.9
-
3
-
-
0023853763
-
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination
-
Orekhov AN, Tertov VV, Pokrovsky SN, Adamova IYu, Martsenyuk ON, Lyakishev AA, Smirnov VN. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ Res 1988;62:421-429.
-
(1988)
Circ Res
, vol.62
, pp. 421-429
-
-
Orekhov, A.N.1
Tertov, V.V.2
Pokrovsky, S.N.3
Adamova, I.4
Martsenyuk, O.N.5
Lyakishev, A.A.6
Smirnov, V.N.7
-
4
-
-
0026770875
-
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation
-
Tertov VV, Orekhov AN, Sobenin IA, Gabbasov ZA, Popov EG, Yaroslavov AA, Smirnov VN. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res 1992;71:218-228.
-
(1992)
Circ Res
, vol.71
, pp. 218-228
-
-
Tertov, V.V.1
Orekhov, A.N.2
Sobenin, I.A.3
Gabbasov, Z.A.4
Popov, E.G.5
Yaroslavov, A.A.6
Smirnov, V.N.7
-
5
-
-
0024246454
-
Ruda MYa, Smirnov VN. Cardiovascular drugs and atherosclerosis: Effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells
-
Orekhov AN, Baldenkov GN, Tertov VV, Ryong LH, Kozlov SG, Lyakishev AA, Tkachuk VA, Ruda MYa, Smirnov VN. Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol 1988;12(Suppl 6):S66-S68.
-
(1988)
J Cardiovasc Pharmacol
, vol.12
, Issue.SUPPL. 6
-
-
Orekhov, A.N.1
Baldenkov, G.N.2
Tertov, V.V.3
Ryong, L.H.4
Kozlov, S.G.5
Lyakishev, A.A.6
Tkachuk, V.A.7
-
6
-
-
69549104946
-
Treatment of Atherosclerosis (In Russian)
-
Pokrovsky AV, ed, Moscow; Meditsina
-
Pivovarova EM. Treatment of Atherosclerosis (In Russian). In: Clinical Angiology. (Pokrovsky AV, ed), Moscow; Meditsina, v. 2, 2004, p. 712-714.
-
(2004)
Clinical Angiology
, vol.2
, pp. 712-714
-
-
Pivovarova, E.M.1
-
7
-
-
0025572219
-
In vitro models of anti-atherosclerotic effects of cardiovascular drugs
-
Orekhov AN. In vitro models of anti-atherosclerotic effects of cardiovascular drugs. Am J Cardiol 1990;66:23I-28I.
-
(1990)
Am J Cardiol
, vol.66
-
-
Orekhov, A.N.1
-
8
-
-
0026653350
-
Beta-blockers: Propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine
-
Orekhov AN, Andrianova IV, Rekhter MD, Tertov VV, Andreeva ER, Ragimov SE, Mironov AA. Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine. Atherosclerosis 1992;95:77-85.
-
(1992)
Atherosclerosis
, vol.95
, pp. 77-85
-
-
Orekhov, A.N.1
Andrianova, I.V.2
Rekhter, M.D.3
Tertov, V.V.4
Andreeva, E.R.5
Ragimov, S.E.6
Mironov, A.A.7
-
9
-
-
0031891822
-
The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells
-
Orekhov AN, Tertov VV, Pivovarova EM. The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells. Cardiology 1998;89:111-118.
-
(1998)
Cardiology
, vol.89
, pp. 111-118
-
-
Orekhov, A.N.1
Tertov, V.V.2
Pivovarova, E.M.3
-
10
-
-
0022528767
-
Khashimov KhA, Smirnov VN. Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents
-
Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN. Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis 1986;60:101-110.
-
(1986)
Atherosclerosis
, vol.60
, pp. 101-110
-
-
Orekhov, A.N.1
Tertov, V.V.2
Kudryashov, S.A.3
-
11
-
-
0023543726
-
Cyclic nucleotides and atherosclerosis: Studies in primary culture of human aortic cells
-
Tertov VV, Orekhov AN, Kudryashov SA, Klibanov AL, Ivanov NN, Torchilin VP, Smirnov VN. Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells. Exp Mol Pathol 1987;47:377-389.
-
(1987)
Exp Mol Pathol
, vol.47
, pp. 377-389
-
-
Tertov, V.V.1
Orekhov, A.N.2
Kudryashov, S.A.3
Klibanov, A.L.4
Ivanov, N.N.5
Torchilin, V.P.6
Smirnov, V.N.7
-
12
-
-
0026493855
-
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil
-
Orekhov AN, Pivovarova EM, Sobenin IA, Yakushkin VV, Tertov VV. Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil. Drugs 1992;44:105-110.
-
(1992)
Drugs
, vol.44
, pp. 105-110
-
-
Orekhov, A.N.1
Pivovarova, E.M.2
Sobenin, I.A.3
Yakushkin, V.V.4
Tertov, V.V.5
-
13
-
-
77349119324
-
-
7th edition, Crawford MN, DiMarco JP, Paulus WJ, et al, Edinburgh; Mosby
-
Mosca L. Hyperlipidemia. In: Cardiology, 7th edition. (Crawford MN, DiMarco JP, Paulus WJ, et al.), Edinburgh; Mosby, 2004: p. 73-90.
-
(2004)
Cardiology
, pp. 73-90
-
-
Hyperlipidemia, M.L.1
-
14
-
-
77349108291
-
-
4th Edition. (Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW), New York; McGrow-Hill
-
Kraemer BF. Miller JW. Dyslipidemias In Clinical Pharmacology, 4th Edition. (Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW), New York; McGrow-Hill, 2000: p. 552-580.
-
(2000)
Dyslipidemias In Clinical Pharmacology
, pp. 552-580
-
-
Kraemer, B.F.1
Miller, J.W.2
-
16
-
-
32644460466
-
Familial hypercholesterolaemia
-
Marais AD. Familial hypercholesterolaemia. Clin Biochem Rev 2004; 25:49-68.
-
(2004)
Clin Biochem Rev
, vol.25
, pp. 49-68
-
-
Marais, A.D.1
-
17
-
-
69549084777
-
Cell culture as a testing system for anti-atherogenic substances: A brief communication
-
Accessed on 04.11.2009. Available at: URL
-
Jargin SV. Cell culture as a testing system for anti-atherogenic substances: a brief communication. Accessed on 04.11.2009. Available at: URL: http://www.actapharmasciencia.org/archive.asp. Acta Pharm Sci 2008;50:237-240.
-
(2008)
Acta Pharm Sci
, vol.50
, pp. 237-240
-
-
Jargin, S.V.1
|